Decline in Community-Acquired Alveolar Pneumonia Positive for Respiratory Syncytial Virus in Hospitalized Children Following Implementation of Pneumococcal Conjugate Vaccine (PCV) in Israel
Dagan R, van der Beek B, Grupel T, Greenberg D, Keren-Naus A, Ben-Shimol S, Weinberger D. Decline in Community-Acquired Alveolar Pneumonia Positive for Respiratory Syncytial Virus in Hospitalized Children Following Implementation of Pneumococcal Conjugate Vaccine (PCV) in Israel. Clinical Infectious Diseases 2025, ciaf102. PMID: 40052957, DOI: 10.1093/cid/ciaf102.Peer-Reviewed Original ResearchPneumococcal conjugate vaccineImpact of pneumococcal conjugate vaccinesConjugate vaccineCommunity-acquired alveolar pneumoniaPneumococcal conjugate vaccine implementationImplementation of pneumococcal conjugate vaccinesRespiratory syncytial virusAnnual hospitalization rateCommunity-acquiredAlveolar pneumoniaSyncytial virusPCV13 implementationAnnual incidenceYoung childrenHospitalization ratesIncidenceRSVMonthsVaccineChildrenEpisodesRegression modelsSynergistic rolePCV13Binomial regression models
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply